The presence of IUGR may influence neonatal levels of magnesium, suggesting an effect on the modulation of this ion homeostasis, during the perinatal period.
The pathophysiology of perinatal hypoxic-ischemic insults has been investigated exhaustively to identify the components that must be blocked to reduce neurologic injury in the newborn. Among potential therapeutic strategies for neuroprotection, administration of magnesium has been the object of experimental studies and, recently, clinical trials. This interest is related to the compound's potential effect of blocking glutamate-controlled N-methyl-D-aspartate (NMDA) receptors and the voltage-dependent calcium channels, preventing the influx of extracellular calcium into the neurons, as well as its action as a membrane stabilizer. To date, results have been variable and are not sufficient to recommend this therapy in newborns who have perinatal asphyxia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.